Page last updated: 2024-10-23

atenolol and Pseudotumor Cerebri

atenolol has been researched along with Pseudotumor Cerebri in 1 studies

Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.

Pseudotumor Cerebri: A condition marked by raised intracranial pressure and characterized clinically by HEADACHES; NAUSEA; PAPILLEDEMA, peripheral constriction of the visual fields, transient visual obscurations, and pulsatile TINNITUS. OBESITY is frequently associated with this condition, which primarily affects women between 20 and 44 years of age. Chronic PAPILLEDEMA may lead to optic nerve injury (see OPTIC NERVE DISEASES) and visual loss (see BLINDNESS).

Research Excerpts

ExcerptRelevanceReference
"Pseudotumor cerebri is characterized by increased intracranial pressure and papilledema, with an essentially normal neurologic examination."1.27Pseudotumor cerebri. ( Bowman, MA, 1987)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bowman, MA1

Other Studies

1 other study available for atenolol and Pseudotumor Cerebri

ArticleYear
Pseudotumor cerebri.
    American family physician, 1987, Volume: 35, Issue:1

    Topics: Acetazolamide; Adult; Atenolol; Cerebrospinal Fluid Shunts; Female; Humans; Intracranial Pressure; P

1987